/R E P E A T -- Media Advisory - Government of Canada to make an announcement in support of Black Canadian communities/

CNW Group
·1 min read

GATINEAU, QC, Feb. 7, 2023 /CNW/ - The Minister of Housing and Diversity and Inclusion, Ahmed Hussen, Minister for Women and Gender Equality and Youth, Marci Ien, Parliamentary Secretary to the Minister of Housing and Diversity and Inclusion (Diversity and Inclusion), Paul Chiang and Member of Parliament for London West, Arielle Kayabaga, will be making an important announcement in Canada's efforts to improve social and economic outcomes in Black communities.

Media availability will follow the announcement.

Please note that all details are subject to change. All times are local.

Date:

Wednesday, February 8, 2023



Time:

9:15 a.m. EST



Place:

Parliament Hill Foyer


West Block - Second floor


111 Wellington Street


Ottawa, Ontario

Participation is in person and for accredited members of the Press Gallery only. Media who are not members of the Press Gallery may contact pressres2@parl.gc.ca for temporary access.

Follow us on Twitter

SOURCE Employment and Social Development Canada

Cision
Cision

View original content: http://www.newswire.ca/en/releases/archive/February2023/08/c4857.html

Latest Stories

  • 7 Obvious Mistakes You Should Sort Out If You Want Your Houseplants To Thrive This Spring

    Turns out we can't even water plants correctly.

  • Atlas and Poseidon Announce Completion of Acquisition by Poseidon Acquisition Corp.

    Atlas Corp. ("Atlas" or the "Company") (NYSE: ATCO) and Poseidon Acquisition Corp. ("Poseidon"), an entity formed by certain affiliates of Fairfax Financial Holdings Limited ("Fairfax"), certain affiliates of the Washington Family ("Washington"), David Sokol, Chairman of the Board of Atlas, and Ocean Network Express Pte. Ltd. ("ONE"), and certain of their respective affiliates, today announced the completion of the previously announced transaction pursuant to which Poseidon acquired all outstand

  • Net Asset Value(s)

    LONDON, March 28, 2023-- FundsDate

  • 8 of the best Kate Spade purses you can shop right now

    We've rounded up the best Kate Spade purses you can get today. From chic tote bags to trendy satchels, these are our favorite Kate Spade accessories.

  • Afghan refugees ‘evictions plan’ deeply concerning, say campaigners

    It comes after reports suggested Afghan refugees are set to be forced out of hotels as part of new Government plans.

  • VERSABANK TO PRESENT AT INVESTOR SUMMIT CONFERENCE ON WEDNESDAY, MARCH 29, 2023 AT 10:30 AM ET

    VersaBank ("VersaBank" or the "Bank") (TSX: VBNK) (NASDAQ: VBNK), a leader in digital banking and cybersecurity solutions, today announced that David Taylor, President and Chief Executive Officer, will present virtually at the Investor Summit Conference on on Wednesday, March 29 – 10:30 am ET.

  • Psyched Wellness Is Pleased to Announce Recent Neurobehavioral Study Evaluating Efficacy and Safety of AME-1

    Toronto, Ontario--(Newsfile Corp. - March 28, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce the company KGK, a licensed CRO in Canada, has completed the last study on the safety and efficacy of AME-1 extract. The result of the study shows that AME-1 alone or in combination with ethanol did not ...

  • PATHWAY ANNOUNCES FINAL DRAW-DOWN UNDER BRIDGE LOAN

    Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce that, further to its press releases of February 3, 2023, February 9, 2023 and February 17, 2023, it has made its third and final draw in the amount of $250,000 (the "Draw Down") under the $1.25 million secured convertible promissory grid note (the "Note") with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc., and

  • Grown Rogue Reports First Quarter 2023 Results, Record Operating Cash Flow and Free Cash Flow

    Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE: GRIN) (OTC: GRUSF), a craft cannabis company operating in Oregon and Michigan, is pleased to report its fiscal first quarter 2023 results for the three months ended January 31, 2023. All financial information is provided in U.S. dollars unless otherwise indicated.

  • Semantix Acquires Health Data Software and Operations to Expand Presence in the Pharma Industry

    SÃO PAULO, Brazil, March 28, 2023 (GLOBE NEWSWIRE) -- Semantix Inc., a leading Latin American end-to-end data and enterprise AI platform provider (“Semantix”), today announced the acquisition of ATSaúde’s assets, businesses, and operations as part of the company’s strategic plan to expand its offerings and presence in the Healthcare & Life Science industry in Brazil, with a specific focus on the pharmaceutical industry. Semantix's CEO, Leonardo Santos, said, "The pharma industry offers a huge op

  • FirstService Corporation Announces Upcoming Meeting and Financial Reporting Dates

    Annual and Special Meeting of Shareholders on April 6, 2023 Release of First Quarter 2023 Results on April 26, 2023 TORONTO, March 28, 2023 (GLOBE NEWSWIRE) -- FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that it will hold its Annual and Special Meeting of Shareholders on Thursday, April 6, 2023 at 11:00 a.m. ET. The meeting will be webcast live and can be either accessed via FirstService’s website at www.firstservice.com in the “Investors” section under the “N

  • Franklin Templeton Canada Announces Plans to Simplify Fund Lineup by Offering Single Funds with Both ETF and Mutual Fund Series

    Franklin Templeton Canada today announced that it is streamlining its product lineup by adding ETF series to select mutual funds, instead of offering separate standalone ETFs. To facilitate this, nine fund mergers are being proposed, which will be voted on at special meetings of investors to be held on June 29, 2023, in Toronto.

  • Semantix Releases GenAI: A Platform for AI Development and Deployment

    SÃO PAULO, Brazil, March 28, 2023 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX), a leading Latin American end-to-end data and enterprise AI platform provider (“Semantix”), today announced the launch of Semantix GenAI, an industry-agnostic set of tools designed to streamline the development, training, and deployment of AI applications for businesses. Semantix GenAI empowers businesses to easily and effectively harness the power of AI, optimizing processes through automated decision-making and

  • Ventana Research Names beqom as "Exemplary Vendor" in Total Compensation Value Index for 2023

    NEW YORK & NYON, Switzerland, March 28, 2023--beqom was rated as a Value Index Leader and an "Exemplary Vendor" in the Ventana Research Total Compensation Management (TCM) Value Index for 2023.

  • Verifone Announces Horizon Program for its Petroleum and Convenience Store Partners

    An upgraded partner program allows technology partners enhanced, secure access to Verifone’s Commander Site Controller ecosystem Verifone Announces Horizon Program for its Petroleum and Convenience Store Partners An upgraded partner program allows technology partners enhanced, secure access to Verifone’s Commander Site Controller ecosystem CORAL SPRINGS, Fla., March 28, 2023 (GLOBE NEWSWIRE) -- Verifone, a global FinTech leader and payment solution provider to the world’s best-known brands, toda

  • Radiopharm Theranostics Invited to Participate in Jefferies Radiopharma Innovation Summit

    SYDNEY, Australia, March 28, 2023 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that the Company will participate in Jefferies Inaugural Radiopharma Innovation Summit being held in New York City on April 3rd, 2023. Riccardo Canevari, Chief Executive Officer and Managing Director of Radiopharm Theranostics, and Vittorio Puppo, Chief Operating Officer

  • Optical Spectrum Analyzer Market Size to Surpass US$ 630 Million by 2033 & Anticipated to progress at a CAGR of 5.7%: Future Market Insights, Inc.

    Optical spectrum analyzer market is considerably gaining from the rising demand in the IT and telecommunication industry. Portable optical spectrum analyzer is gaining traction as more preferred products among various industries. From 2023 to 2033, China Optical Spectrum Analyzer Market is estimated to grow at a CAGR of 7.0%NEWARK, Del, March 28, 2023 (GLOBE NEWSWIRE) -- In 2023, the global optical spectrum analyzer market Size is expected to be worth US$ 361.8 million. The market is expected to

  • Nevada Sunrise Receives Additional Lithium Analyses - GEM23-04 Mineralization Improves to 1,412 ppm Lithium in Sediments over 1,440 Feet and up to 490 mg/L Lithium in Groundwater at the Gemini Lithium Project, Nevada

    Nevada Sunrise Metals Corp. ("Nevada Sunrise", or the "Company") (TSXV: NEV) (OTC: NVSGF) is pleased to announce that the Company has received final geochemical analyses for lithium mineralization in sediment and groundwater samples collected from borehole GEM23-04, drilled at its 100%-owned Gemini Lithium Project ("Gemini") located in the Lida Valley basin in Esmeralda County, Nevada. Drilling of borehole GEM23-04 was completed to a depth of 1,950 feet (594.51 metres), which represents the deep

  • Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

    Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45 million development milestone paymentTARRYTOWN, N.Y., and SOUTH SAN FRANCISCO, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sonoma Biotherapeutics, Inc. today announced a collaboration to apply their scientific and clinical expertise and respective technology platforms to the discovery, development

  • Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

    Announced positive interim data from the Phase 2b ORIGIN clinical trial of atacicept in IgAN, which showed a 41% mean reduction in proteinuria versus baseline in the 150mg dose group at 24 weeks36-week data from the Phase 2b ORIGIN clinical trial of atacicept in IgAN on track for the second quarter of 2023Management prioritizing advancement of atacicept in IgAN, plans to initiate Phase 3 clinical trial in second quarter of 2023 Strong balance sheet expected to fund IgAN-focused operations to ear